These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35292065)

  • 1. Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma.
    Deng L; Yang X; Ding Y; Fan J; Peng Y; Xu D; Huang B; Hu Z
    Virol J; 2022 Mar; 19(1):44. PubMed ID: 35292065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer.
    Deng L; Yang X; Fan J; Ding Y; Peng Y; Xu D; Huang B; Hu Z
    Oncol Res; 2021 Mar; 28(6):579-590. PubMed ID: 32641200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target Therapy With Vaccinia Virus Harboring IL-24 For Human Breast Cancer.
    Deng L; Fan J; Ding Y; Yang X; Huang B; Hu Z
    J Cancer; 2020; 11(5):1017-1026. PubMed ID: 31956348
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic cancer therapy with a vaccinia virus strain.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B; Hu Z
    Oncol Rep; 2019 Jan; 41(1):686-692. PubMed ID: 30365140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Oncolytic Vaccinia Virus Armed with GM-CSF and IL-24 Double Genes for Cancer Targeted Therapy.
    Deng L; Yang X; Fan J; Ding Y; Peng Y; Xu D; Huang B; Hu Z
    Onco Targets Ther; 2020; 13():3535-3544. PubMed ID: 32425553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
    El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
    J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL-24 gene in liver cancer cells.
    Wang C; Li Q; Xiao B; Fang H; Huang B; Huang F; Wang Y
    J Clin Lab Anal; 2021 Mar; 35(3):e23677. PubMed ID: 33274495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
    Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
    Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
    Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
    PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma.
    Ady JW; Johnsen C; Mojica K; Heffner J; Love D; Pugalenthi A; Belin LJ; Chen NG; Yu YA; Szalay AA; Fong Y
    Surgery; 2015 Aug; 158(2):331-8. PubMed ID: 26049609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined anti-tumor efficacy of somatostatin fusion protein and vaccinia virus on tumor cells with high expression of somatostatin receptors.
    Fan J; Deng L; Peng Y; Ding Y
    Sci Rep; 2022 Oct; 12(1):16885. PubMed ID: 36207478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma.
    Penghui Y; Fang S; Ruilan W; Guanglin L; Hongjing G; Yueqiang D; Zhongpeng Z; Xiaolan Y; Zhaohai W; Shaogeng Z; Xiliang W
    Hum Gene Ther; 2019 Mar; 30(3):330-338. PubMed ID: 30205709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
    Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
    Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently.
    Ady JW; Heffner J; Mojica K; Johnsen C; Belin LJ; Love D; Chen CT; Pugalenthi A; Klein E; Chen NG; Yu YA; Szalay AA; Fong Y
    Surgery; 2014 Aug; 156(2):263-9. PubMed ID: 24957667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.
    Ma B; Wang Y; Zhou X; Huang P; Zhang R; Liu T; Cui C; Liu X; Wang Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):419-29. PubMed ID: 25240826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.